SOPH
Sophia Genetics SA
NASDAQ: SOPH · HEALTHCARE · HEALTH INFORMATION SERVICES
$5.28
+5.60% today
Updated 2026-04-29
Market cap
$358.34M
P/E ratio
—
P/S ratio
4.64x
EPS (TTM)
$-1.17
Dividend yield
—
52W range
$3 – $6
Volume
0.1M
Sophia Genetics SA (SOPH) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-102.20%
Operating margin
-85.40%
ROE
-110.00%
ROA
-27.90%
Debt/equity
1.04x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | $25.36M | $-33.79M | 70.30% | -127.30% | -133.23% |
| 2020 | $28.40M | $-39.34M | 62.29% | -131.64% | -138.52% |
| 2021 | $40.45M | $-73.67M | 62.35% | -176.73% | -182.14% |
| 2022 | $47.56M | $-87.45M | 65.71% | -184.66% | -183.87% |
| 2023 | $62.37M | $-78.98M | 68.80% | -119.97% | -126.63% |
| 2024 | $65.17M | $-62.49M | 67.42% | -102.14% | -95.89% |
| 2025 | $77.27M | $-79.00M | 61.88% | -91.79% | -102.24% |